These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Retroperitoneal synovial sarcoma: a clinicopathological study of 6 cases. Chatzipantelis P; Kafiri G J BUON; 2008; 13(2):211-6. PubMed ID: 18555467 [TBL] [Abstract][Full Text] [Related]
3. Differential Ki67 and bcl-2 immunoexpression in solid-glandular and spindle cell components of biphasic synovial sarcoma: a double immunostaining assessment with cytokeratin and vimentin. Lopes JM; Nesland JM; Reis-Filho JS; Holm R Histopathology; 2002 May; 40(5):464-71. PubMed ID: 12010367 [TBL] [Abstract][Full Text] [Related]
4. TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies. Terry J; Saito T; Subramanian S; Ruttan C; Antonescu CR; Goldblum JR; Downs-Kelly E; Corless CL; Rubin BP; van de Rijn M; Ladanyi M; Nielsen TO Am J Surg Pathol; 2007 Feb; 31(2):240-6. PubMed ID: 17255769 [TBL] [Abstract][Full Text] [Related]
5. Primary intraabdominal synovial sarcoma: a case report. Buiga-Potcoavă R; Crişan D; Olinici CD Rom J Gastroenterol; 2005 Mar; 14(1):67-9. PubMed ID: 15800696 [TBL] [Abstract][Full Text] [Related]
6. Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression. Izumi T; Oda Y; Hasegawa T; Nakanishi Y; Kawai A; Sonobe H; Takahira T; Kobayashi C; Yamamoto H; Tamiya S; Hirohashi S; Iwamoto Y; Tsuneyoshi M Am J Surg Pathol; 2007 Jan; 31(1):85-94. PubMed ID: 17197923 [TBL] [Abstract][Full Text] [Related]
7. Synovial sarcoma of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 10 cases. Makhlouf HR; Ahrens W; Agarwal B; Dow N; Marshalleck JJ; Lee EL; Dotto JE; Hui P; Sobin LH; Oliveira A; Miettinen M Am J Surg Pathol; 2008 Feb; 32(2):275-81. PubMed ID: 18223331 [TBL] [Abstract][Full Text] [Related]
8. Synovial sarcoma: an immunohistochemical and ultrastructural study. Ordóñez NG; Mahfouz SM; Mackay B Hum Pathol; 1990 Jul; 21(7):733-49. PubMed ID: 2163364 [TBL] [Abstract][Full Text] [Related]
10. Molecular detection of SS18-SSX fusion gene transcripts by cRNA in situ hybridization in synovial sarcoma using formalin-fixed, paraffin-embedded tumor tissue specimens. Kanemitsu S; Hisaoka M; Shimajiri S; Matsuyama A; Hashimoto H Diagn Mol Pathol; 2007 Mar; 16(1):9-17. PubMed ID: 17471153 [TBL] [Abstract][Full Text] [Related]
11. [Synovial sarcoma. Immunohistochemical study of 4 cases]. Cavaliere A; Sidoni A; Alberti PF; Bucciarelli E Pathologica; 1994 Feb; 86(1):77-81. PubMed ID: 8072807 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical profile of synovial sarcoma with emphasis on the epithelial-type differentiation. A study of 49 primary tumours, recurrences and metastases. Lopes JM; Bjerkehagen B; Holm R; Bruland O; Sobrinho-Simões M; Nesland JM Pathol Res Pract; 1994 Feb; 190(2):168-77. PubMed ID: 7520165 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical markers to distinguish between hemangioblastoma and metastatic clear-cell renal cell carcinoma in the brain: utility of aquaporin1 combined with cytokeratin AE1/AE3 immunostaining. Weinbreck N; Marie B; Bressenot A; Montagne K; Joud A; Baumann C; Klein O; Vignaud JM Am J Surg Pathol; 2008 Jul; 32(7):1051-9. PubMed ID: 18496143 [TBL] [Abstract][Full Text] [Related]
14. Spindle epithelial tumor with thymus-like differentiation: a morphologic, immunohistochemical, and molecular genetic study of 11 cases. Folpe AL; Lloyd RV; Bacchi CE; Rosai J Am J Surg Pathol; 2009 Aug; 33(8):1179-86. PubMed ID: 19417583 [TBL] [Abstract][Full Text] [Related]
15. Utility of cytokeratin subsets for distinguishing poorly differentiated synovial sarcoma from peripheral primitive neuroectodermal tumour. Machen SK; Fisher C; Gautam RS; Tubbs RR; Goldblum JR Histopathology; 1998 Dec; 33(6):501-7. PubMed ID: 9870143 [TBL] [Abstract][Full Text] [Related]
16. Molecular and immunohistochemical analyses of BCL2, KI-67, and cyclin D1 expression in synovial sarcoma. Krsková L; Kalinová M; Brízová H; Mrhalová M; Sumerauer D; Kodet R Cancer Genet Cytogenet; 2009 Aug; 193(1):1-8. PubMed ID: 19602458 [TBL] [Abstract][Full Text] [Related]
18. Primary synovial sarcoma arising in the parotid region diagnosed by fluorescence in situ hybridization. Kawata R; Terada T; Takenaka H; Kurisu Y; Tsuji M Auris Nasus Larynx; 2008 Dec; 35(4):583-6. PubMed ID: 18262374 [TBL] [Abstract][Full Text] [Related]
19. Primary monophasic synovial sarcoma of the duodenum with SYT/SSX2 type of translocation. Schreiber-Facklam H; Bode-Lesniewska B; Frigerio S; Flury R Hum Pathol; 2007 Jun; 38(6):946-9. PubMed ID: 17509396 [TBL] [Abstract][Full Text] [Related]
20. [Expressions and significance of E-cadherin and beta-catenin in synovial sarcoma]. Sun BC; Sun Y; Zhao XL; Liu YX; Zhang SW; Liu YX Zhonghua Zhong Liu Za Zhi; 2005 Dec; 27(12):727-30. PubMed ID: 16483482 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]